Atlas FDA

HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM

FDA 510(k) clearance K820192 · decided 1982-03-11

Clearance details

K-number
K820192
Device name
HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM
Applicant
Hyland Therapeutic Div., Travenol Laboratories
Decision
Substantially Equivalent
Date received
1982-01-25
Decision date
1982-03-11
Days to decision
45 days
Clearance type
Traditional
Product code
GRP
Device class
2
Regulation number
866.3300
Medical specialty
Microbiology
Advisory committee
Microbiology
Location
Walker, MI, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Hyland Therapeutic Div.

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
BACTIGEN(R) H. INFLUENZAE TYPE B (K884967)Armkel, LLC1989-02-07
IMMUNOSCAN DIRECT HEMOPHILUS INFLUENZAE TYPE B TES (K854490)American Micro Scan1985-12-27
H-FLU B ELISA TEST (K831525)Seragen Diagnostics, Inc.1983-09-29
H. INFLUENZA B ANTISERA FOR CIE (K823348)Diagnostica, Inc.1982-12-28
BBL DIRECTIGEN MENINGITIS TEST KIT (K821266)Bd Becton Dickinson Vacutainer Systems Preanalytic1982-06-01

Recalls involving this device

No recalls on record reference this clearance.